Type 2 Diabetes: Progress Made but Still a Long Road to Travel to Reduce Disease Burden

被引：1
作者：
Terra, S. G. [1 ]
Vincent, J. [2 ]
机构：
[1] Pfizer Inc, GIPB, Groton, CT 06340 USA
[2] Pfizer Inc, New York, NY 10017 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 98卷 / 02期
关键词：
CARDIOVASCULAR-DISEASE; RISK; HYPERGLYCEMIA; MELLITUS; OBESITY;
D O I：
10.1002/cpt.154
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：108 / 111
页数：4
相关论文
共 18 条
  • [1] Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications
    Alvarez, C. A.
    Lingvay, I.
    Vuylsteke, V.
    Koffarnus, R. L.
    McGuire, D. K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (02) : 145 - 161
  • [2] The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future
    Bailey, C. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (02) : 170 - 184
  • [3] BANTING FG, 1991, CAN MED ASSOC J, V145, P1281
  • [4] Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study
    Barr, E. L. M.
    Boyko, E. J.
    Zimmet, P. Z.
    Wolfe, R.
    Tonkin, A. M.
    Shaw, J. E.
    [J]. DIABETOLOGIA, 2009, 52 (03) : 415 - 424
  • [5] Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
    Cederberg, Henna
    Stancakova, Alena
    Yaluri, Nagendra
    Modi, Shalem
    Kuusisto, Johanna
    Laakso, Markku
    [J]. DIABETOLOGIA, 2015, 58 (05) : 1109 - 1117
  • [6] A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease
    Eknoyan, G
    Nagy, J
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (02) : 223 - 229
  • [7] Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
    Gerstein, Hertzel C.
    Bosch, Jackie
    Dagenais, Gilles R.
    Diaz, Rafael
    Jung, Hyejung
    Maggioni, Aldo P.
    Pogue, Janice
    Probstfield, Jeffrey
    Ramachandran, Ambady
    Riddle, Matthew C.
    Ryden, Lars E.
    Yusuf, Salim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04) : 319 - 328
  • [8] NEWLY DIAGNOSED DIABETES AND PRE-DIABETES IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION PREDICTS ADVERSE OUTCOMES DURING A THREE-YEAR FOLLOW-UP: RESULTS OF THE SWEETHEART REGISTRY
    Gitt, Anselm
    Bramlage, Peter
    Towae, Frank
    Papp, Andrea
    Deeg, Evelin
    Senges, Jochen
    Zeymer, Uwe
    Zahn, Ralf
    Fleischmann, Holger
    Boehler, Steffen
    Schnell, Oliver
    Standl, Eberhard
    Tschoepe, Diethelm
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E176 - E176
  • [9] Advanced glycation end products - Sparking the development of diabetic vascular injury
    Goldin, Alison
    Beckman, Joshua A.
    Schmidt, Ann Marie
    Creager, Mark A.
    [J]. CIRCULATION, 2006, 114 (06) : 597 - 605
  • [10] Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    Grundy, SM
    Pasternak, R
    Greenland, P
    Smith, S
    Fuster, V
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) : 1348 - 1359
12